CLASSIFICATION
Glycoprotein Cytokine
ACNE
No
WATER RETENTION
No
HBR
No
HEPATOTOXICITY
No
AROMATIZATION
No
MANUFACTURER
Drogsan
WAREHOUSE
International Warehouse 2
SUBSTANCE
Erythropoietin
Indications for Dropoetin:
Dropoetin is expertly formulated to manage anemia associated with chronic kidney failure in both children and adults undergoing hemodialysis or peritoneal dialysis. Additionally, it is effective for treating severe renal-related anemia in adults exhibiting clinical symptoms, even if they haven't started dialysis.
This powerful medication is especially beneficial for adult cancer patients (with non-myeloid malignancies) undergoing chemotherapy, as it helps combat anemia and reduces the reliance on blood transfusions.
For adults living with HIV who are on zidovudine treatment and show low endogenous Dropoetin levels (?500 mU/ml), Dropoetin serves as an effective solution for managing anemia.
Adults experiencing moderate anemia (with hematocrit levels between 33-39% and hemoglobin levels of 10-13 g/dL, absent iron deficiency) and scheduled for major elective surgeries may also benefit from Dropoetin, helping facilitate autologous blood collection and minimizing the need for allogeneic blood transfusions. This treatment is recommended only when other blood conservation methods fall short for surgeries expected to require significant blood volume (4 or more units for females or 5 or more units for males).
Moreover, Dropoetin is indicated to promote erythropoiesis during the perioperative period, reducing the risk of allogeneic blood transfusions and addressing postoperative anemia in adult patients without iron deficiency undergoing major elective orthopedic surgeries. This application is specifically for those with moderate anemia (e.g., Hb 10-13 g/dL) lacking access to autologous predonation programs and anticipating moderate blood loss (900 to 1800 ml).
Finally, Dropoetin is recommended for treating anemia in patients with Low or Intermediate 1-risk Myelodysplastic Syndrome (MDS) who have hemoglobin levels below 10 g/dL.
Using Dropoetin:
Administer Dropoetin exactly as prescribed by your healthcare provider. Always refer to the medication label for precise dosing instructions. A Medication Guide will accompany Dropoetin; please take the time to read it thoroughly and keep it handy for reference with each refill.
Dropoetin is typically administered via injection in a doctor's office, hospital, or clinic. If you opt to use Dropoetin at home, a healthcare professional will guide you through the proper usage techniques, which are essential for your safety. Follow all provided instructions meticulously, and don?t hesitate to reach out to your healthcare provider with any questions.
When preparing your dose, follow the demonstrated techniques to prevent contamination of the vial, syringe, or medication. Avoid touching the rubber stopper of the vial or the syringe needle with your fingers. Always double-check that you have drawn the correct dose before administration.
Do not shake Dropoetin, and refrain from using it if it has been shaken or frozen. Avoid diluting or mixing Dropoetin with other solutions unless specifically directed by your physician.
For single-dose vials, dispose of any unused medication immediately after taking your dose. Consult your doctor, pharmacist, or healthcare provider for proper disposal methods regarding single-dose vials.
Do not use Dropoetin if it appears cloudy, discolored, contains particles, or if the vial is damaged. Store Dropoetin, syringes, and needles safely out of reach of children and pets. Never reuse needles, syringes, or other supplies. Ask your healthcare provider about the best disposal practices for these items, ensuring adherence to local disposal regulations.
Continue taking Dropoetin as prescribed, even if you feel well, and ensure you do not miss any doses. If you do miss a dose, contact your doctor promptly.
Feel free to reach out to your healthcare provider with any questions regarding the use of Dropoetin.
Dropoetin Side Effects:
The following serious adverse effects are detailed further in other sections of the label:
- Increased Mortality
- Myocardial Infarction
- Stroke
- Thromboembolism
- Higher risk of mortality and/or increased chance of tumor progression or recurrence in cancer patients
- Hypertension
- Seizures
- Pure Red Cell Aplasia (PRCA)
- Severe allergic reactions